Tasso and partners receive $4.25M to develop a universal surveillance platform for infectious disease outbreaks

September 28, 2017

Tasso, Inc. (Tasso), Ceres Nanosciences (Ceres), George Mason University (Mason), and the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) today announced the commencement of an $11.7 million program, funded by the Defense Threat Reduction Agency (DTRA), to develop a reliable, safe, and simple universal surveillance platform for infectious disease outbreaks.

Read More
Arna Ionescu Stoll